1 active trial for Glycogen Storage Disease Type II Pompe Disease

Avalglucosidase Alfa Extension Study

Primary Objective: Long-term safety and pharmacokinetics (PK) of avalglucosidase alfa Secondary Objective: Long-term effect of avalglucosidase alfa on pharmacodynamic and exploratory efficacy variables

Start: February 2014